Zobrazeno 1 - 10
of 825
pro vyhledávání: '"Bougea A"'
Publikováno v:
Clinical and Experimental Gastroenterology, Vol 2016, Iss Issue 1, Pp 143-149 (2016)
Nikolaos Spantideas,1 Eirini Drosou,1 Anastasia Bougea,2 Dimitrios Assimakopoulos,3 1Athens Speech Language and Swallowing Institute, Glyfada, Athens, Greece; 2Athens Speech Language and Swallowing Institute, Agios Dimitrios, Athens, Greece; 3Departm
Externí odkaz:
https://doaj.org/article/a0a613a9c7204662b66077b2471936b4
Autor:
Christos Koros, Athina-Maria Simitsi, Nikolaos Papagiannakis, Anastasia Bougea, Roubina Antonelou, Ioanna Pachi, Evangelos Sfikas, Evangelia Stanitsa, Efthalia Angelopoulou, Vasilios C. Constantinides, Sokratis G. Papageorgiou, Constantin Potagas, Maria Stamelou, Leonidas Stefanis
Publikováno v:
Neurology International, Vol 16, Iss 4, Pp 833-844 (2024)
Introduction: Parkinson’s disease (PD) patients harboring recessive gene variants exhibit a distinct clinical phenotype with an early disease onset and relatively mild symptoms. Data concerning individualized therapy for autosomal recessive PD form
Externí odkaz:
https://doaj.org/article/8c7102d2e86c4bd3a8de511784e635a4
Autor:
Bougea, Anastasia1 (AUTHOR) abougea@med.uoa.gr
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10783. 24p.
Autor:
Bougea, Anastasia1 (AUTHOR) abougea@med.uoa.gr, Gourzis, Philippos2 (AUTHOR) pgourzis@upatras.gr
Publikováno v:
Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 16, p4661. 25p.
Autor:
Angelopoulou, Efthalia1 (AUTHOR) angelthal@med.uoa.gr, Bougea, Anastasia1 (AUTHOR) abougea@med.uoa.gr, Hatzimanolis, Alexandros2 (AUTHOR) alhatzi@med.uoa.gr, Scarmeas, Nikolaos1 (AUTHOR) sokpapa@med.uoa.gr, Papageorgiou, Sokratis G.1 (AUTHOR)
Publikováno v:
Cells (2073-4409). Jul2024, Vol. 13 Issue 13, p1164. 29p.
Autor:
Bougea, Anastasia1 (AUTHOR) abougea@med.uoa.gr, Angelopoulou, Efthalia1 (AUTHOR) sokpapa@med.uoa.gr, Vasilopoulos, Efthimios2 (AUTHOR) efvasilop@med.uoa.gr, Gourzis, Philippos2,3 (AUTHOR) pgourzis@upatras.gr, Papageorgiou, Sokratis1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6542. 16p.
Autor:
Efthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, Nikolaos Scarmeas, Sokratis G. Papageorgiou
Publikováno v:
Cells, Vol 13, Iss 13, p 1164 (2024)
The emergence of sustained neuropsychiatric symptoms (NPS) among non-demented individuals in later life, defined as mild behavioral impairment (MBI), is linked to a higher risk of cognitive decline. However, the underlying pathophysiological mechanis
Externí odkaz:
https://doaj.org/article/6f705644d10e475f955d5e74496d3f98
Publikováno v:
Medicina, Vol 60, Iss 6, p 873 (2024)
Background and Objectives: Currently, no tool exists to predict clinical outcomes in patients with advanced Parkinson’s disease (PD) under levodopa–carbidopa intestinal gel (LCIG) treatment. The aim of this study was to develop a novel deep neura
Externí odkaz:
https://doaj.org/article/47a83d48e2644e5d981c0a7ab106c3f9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anastasia Bougea
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 549 (2024)
In light of the unsuccessful traditional therapies for Parkinson’s disease (PD) overmany years, there is an unmet need for the development of novel therapies to alleviate the symptoms of PD retardation or halt the progression of the disease itself.
Externí odkaz:
https://doaj.org/article/6003b5a33a254582aec584197885f2b0